Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
November 13, 2004
EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil
Michael T Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 21, 2001
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam
M Saletu, P Anderer, G Saletu-Zyhlarz, et al.
Wiener Klinische Wochenschrift
|
May 18, 2000
[Daytime tiredness correlated with nocturnal respiratory and arousal variables in patients with sleep apnea: polysomnographic and EEG mapping studies]
M Saletu, C Hauer, P Anderer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
April 15, 2004
Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mapping
Gerda M Saletu-Zyhlarz, Oliver Arnold, Peter Anderer, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1990
Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria
G F Hebenstreit, M Loidl, U Baumhackl, et al.
Neuropsychobiology
|
April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings
Gerda M Saletu-Zyhlarz, Peter Anderer, Michael Wolzt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 18, 2002
Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry
B Saletu, P Anderer, L Linzmayer, et al.
Neurology
|
June 16, 2005
Restless legs syndrome: a community-based study of prevalence, severity, and risk factors
B Högl, S Kiechl, J Willeit, et al.
Neuropsychobiology
|
October 5, 2001
Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone
G M Saletu-Zyhlarz, M H Abu-Bakr, P Anderer, et al.
The International Journal of Neuropsychopharmacology
|
October 9, 2002
Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping
Gerda M Saletu-Zyhlarz, Peter Anderer, Leopold Linzmayer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
European Archives of Psychiatry and Clinical Neuroscience
|
November 13, 2004
EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil
Michael T Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 21, 2001
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam
M Saletu, P Anderer, G Saletu-Zyhlarz, et al.
Wiener Klinische Wochenschrift
|
May 18, 2000
[Daytime tiredness correlated with nocturnal respiratory and arousal variables in patients with sleep apnea: polysomnographic and EEG mapping studies]
M Saletu, C Hauer, P Anderer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
April 15, 2004
Differences in brain function between relapsing and abstaining alcohol-dependent patients, evaluated by EEG mapping
Gerda M Saletu-Zyhlarz, Oliver Arnold, Peter Anderer, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1990
Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria
G F Hebenstreit, M Loidl, U Baumhackl, et al.
Neuropsychobiology
|
April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings
Gerda M Saletu-Zyhlarz, Peter Anderer, Michael Wolzt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 18, 2002
Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry
B Saletu, P Anderer, L Linzmayer, et al.
Neurology
|
June 16, 2005
Restless legs syndrome: a community-based study of prevalence, severity, and risk factors
B Högl, S Kiechl, J Willeit, et al.
Neuropsychobiology
|
October 5, 2001
Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone
G M Saletu-Zyhlarz, M H Abu-Bakr, P Anderer, et al.
The International Journal of Neuropsychopharmacology
|
October 9, 2002
Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping
Gerda M Saletu-Zyhlarz, Peter Anderer, Leopold Linzmayer, et al.
Page
of 7